|
|
|
|
|
| Terms & Properties |
Concept Unique Identifier (CUI): C0759933
NCI Thesaurus Code: C65509 (see NCI Thesaurus info)
Semantic Type: Pharmacologic Substance
Semantic Type: Organic Chemical
Synonyms & Abbreviations: (see Synonym Details)
| (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole |
| Eletriptan (substance) |
| Eletriptan-containing product |
| Eletriptanum |
| Eletriptan |
| Eletriptán |
| Product containing eletriptan (medicinal product) |
| élétriptan |
External Source Codes:
| NCI Thesaurus Code | C65509 (see NCI Thesaurus info) |
| CAS Registry Number | 143322-58-1 (see NLM ChemIDplus info) |
| FDA UNII Code | 22QOO9B8KI |
Other Properties:
| Name | Value | Source |
|---|---|---|
| ACTIVE | 1 | SNOMEDCT_US |
| CASE_SIGNIFICANCE_ID | 900000000000448009 | SNOMEDCT_US |
| CHEBI_ID | CHEBI:50922 | NCI |
| Chemical_Formula | C22H26N2O2S | NCI |
| Contributing_Source | FDA | NCI |
| CTV3ID | dlD.. | SNOMEDCT_US |
| CTV3ID | XUbYI | SNOMEDCT_US |
| DEFINITION_STATUS_ID | 900000000000073002 | SNOMEDCT_US |
| DEFINITION_STATUS_ID | 900000000000074008 | SNOMEDCT_US |
| EFFECTIVE_TIME | 20040731 | SNOMEDCT_US |
| EFFECTIVE_TIME | 20180731 | SNOMEDCT_US |
| FDA_UNII_CODE | 22QOO9B8KI | DRUGBANK |
| FR | 164 | MSH |
| HM | D011759 | MSH |
| HM | D014363 | MSH |
| MDA | 19981130 | MSH |
| MMR | 20161103 | MSH |
| PA | D017366 | MSH |
| PI | *INDOLES (1998-2005) | MSH |
| RN | 22QOO9B8KI | MSH |
| RR | M41W832TA3 | MSH |
| RXAUI | 10785314 | RXNORM |
| RXAUI | 10785315 | RXNORM |
| RXAUI | 10785316 | RXNORM |
| RXAUI | 1207054 | RXNORM |
| RXAUI | 1207056 | RXNORM |
| RXAUI | 1207059 | RXNORM |
| RXAUI | 6395330 | RXNORM |
| RXAUI | 6396224 | RXNORM |
| RXAUI | 8380418 | RXNORM |
| RXAUI | 8760069 | RXNORM |
| RXCUI | 231049 | RXNORM |
| SC | 1 | MSH |
| SID | APRD00945 | DRUGBANK |
| SOS | 5-HT(1B/1D) receptor agonist; structure in first source | MSH |
| SPL_SET_ID | 1728c511-d1fd-4e30-85ba-f0f5d996088b | MTHSPL |
| SPL_SET_ID | 20276f5c-f2d6-469f-9a1b-aa254a1db21c | MTHSPL |
| SPL_SET_ID | 481ae7d4-9e57-424a-9d07-2920954b6ddc | MTHSPL |
| SPL_SET_ID | 523b947a-4e92-42ff-886c-4317af8d7b56 | MTHSPL |
| SPL_SET_ID | 62c8e43a-402c-4f71-8ba4-3def66a34174 | MTHSPL |
| SPL_SET_ID | 62dc12ce-4f19-41c6-9593-3cae29f04af1 | MTHSPL |
| SPL_SET_ID | 6bb510c8-2ae2-4159-b4c6-0aec5e64b4c9 | MTHSPL |
| SPL_SET_ID | 726323d8-c9a7-44c1-bb95-08b6c378332c | MTHSPL |
| SPL_SET_ID | 85745375-fcb6-4edc-b6db-a77b4a5f3e8c | MTHSPL |
| SPL_SET_ID | 945285e3-b721-4c9d-9cab-b0615e0602be | MTHSPL |
| SPL_SET_ID | a3953ca6-3da6-4420-9eb5-a16b38372f4e | MTHSPL |
| SPL_SET_ID | a65315d7-a30a-4c1f-95a9-30226e559c3d | MTHSPL |
| SPL_SET_ID | bb5ea5df-4add-420d-88cb-6dabe116ca65 | MTHSPL |
| SPL_SET_ID | e0dfeb1f-f0f0-449a-81ae-2c8fdddcff10 | MTHSPL |
| SPL_SET_ID | f6dc0893-b845-4f96-e053-6294a90a856f | MTHSPL |
| SPL_SET_ID | fd427d2d-b78b-412a-9c80-606bc88ad112 | MTHSPL |
| SRC | Naunyn Schmiedebergs Arch Pharmacol 1998 Aug;358(2):212-9 | MSH |
| SUBSET_MEMBER | 900000000000497000~MAPTARGET~dlD.. | SNOMEDCT_US |
| SUBSET_MEMBER | 900000000000497000~MAPTARGET~XUbYI | SNOMEDCT_US |
| TERMUI | T000911249 | MSH |
| TERMUI | T327681 | MSH |
| TH | FDA SRS (2013) | MSH |
| TH | INN (19XX) | MSH |
| TH | NLM (1998) | MSH |
| TH | NLM (2017) | MSH |
| TYPE_ID | 900000000000003001 | SNOMEDCT_US |
| TYPE_ID | 900000000000013009 | SNOMEDCT_US |
Additional Concept Data: (none)
URL to Bookmark: https://ncim-stage.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI Metathesaurus&code=C0759933
